UnitedHealth Group Incorporated $UNH Shares Acquired by Exchange Traded Concepts LLC

Key Points

• Exchange Traded Concepts LLC increased its holdings in UnitedHealth Group by 48.0%, acquiring a total of 4,184 shares valued at approximately $1.305 million by the end of the second quarter.
• UnitedHealth Group reported earnings per share (EPS) of $4.08 for the last quarter, which missed analysts' expectations, and had a revenue of $111.62 billion, reflecting a year-over-year increase of 12.9%.
• The company declared a quarterly dividend of $2.21 per share, with a yield of 2.6%, set to be paid on September 23rd to investors of record on September 15th.

Exchange Traded Concepts LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 48.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,184 shares of the healthcare conglomerate's stock after purchasing an additional 1,357 shares during the period. Exchange Traded Concepts LLC's holdings in UnitedHealth Group were worth $1,305,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Vermillion Wealth Management Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth $90,000. Ameriflex Group Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth $411,000. Finally, Liberty Square Wealth Partners LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth $221,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $341.49 on Tuesday. The business's 50 day simple moving average is $296.49 and its 200-day simple moving average is $362.50. The firm has a market capitalization of $309.27 billion, a price-to-earnings ratio of 14.80, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the firm earned $6.80 EPS. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

Several research analysts have recently commented on UNH shares. Wells Fargo & Company lowered their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Barclays raised their price target on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Finally, Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.